Cardiac tamponade in systemic sclerosis: A case report and review of 18 reported cases

Journal of Clinical Rheumatology

Volumn 6, Issue 1, 2000, Pages 35-40

  Wooten, Marc D ^a,b   Reddy, Gaddum V ^b   Johnson, Rena D ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b DEPARTMENT OF VETERANS AFFAIRS   (United States)

Author keywords

Anticoagulation; Cardiac tamponade; Pericardial effusion; Systemic sclerosis

Indexed keywords

ANTICOAGULANT AGENT; METHOTREXATE; PREDNISONE;

ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CORTICOSTEROID THERAPY; DATA BASE; DEATH; DISEASE ASSOCIATION; HEART FAILURE; HEART TAMPONADE; HUMAN; MALE; PERICARDIAL EFFUSION; PERICARDIECTOMY; PRIORITY JOURNAL; SCLERODERMA; SEX; SYSTEMIC SCLEROSIS;

EID: 0034006544     PISSN: 10761608     EISSN: None     Source Type: Journal    
DOI: 10.1097/00124743-200002000-00006     Document Type: Article

References (20)

1. Uhl GS, Koppes GM. Fericardial tamponade in systemic sclerosis (scleroderma). Br Heart J 1979;42:345-8.
2. Lee RT, Bhatia SJS, Kirshenbaum JM, Friedman PL. Left ventricular tamponade: echocardiographic and hemodynamic considerations. Clin Cardiol 1989;12:102-4.
3. Sattar MA, Guindi RT, Vajcik J. Pericardial tamponade and limited cutaneous systemic sclerosis (CREST syndrome). Br J Rheumatol 1990;20:306-7.
4. Yebra M, Astigarraga B, Marazuela M, Lacoma F. Pericardial tamponade and limited cutaneous systemic sclerosis. Br J Rheumatol 1991;30:159.
5. Lawrence ME, Robinson JC, Terry EE. Progressive systemic sclerosis causing rapidly progressive myocardial disease and death. South Med J 1992;85:770-2.
6. Wefuan J, Aaron SL. Pericardial disease in scleroderma: prognosis and clinical associations. Clin Exp Rheumatol 1993;11:582-3.
7. Abu-Shakra M, Koh ET, Treger T, Lee P. Pericardial effusion and vasculitis in a patient with systemic sclerosis. J Rheumatol 1995;22:1386-8.
8. Perez-Bocanegra C, Fonollosa V, Simeon CP, Candell J, Solans R, Gomez A, et al. Pericardial tamponade preceding cutaneous involvement in systemic sclerosis. Ann Rheum Dis 1995;54:687-8.
9. Bennis A, Soulami S, Azzouzi L, Tahiri A, Chraibi N. Manifestations cardiaques de la sclerodermie systemique diffuse. Ann Cardiol Angeiol 1995;44:119-24.
10. Satoh M, Tokuhira M, Hama N, Hirakata M, Kuwana M, Akizuki M, et al. Massive pericardial effusion in scleroderma: a review of five cases. Br J Rheumatol 1995;34:564-7.
11. Hordon LD, Turney JH. Massive pericardial effusion in scleroderma. Br J Rheumatol 1996; 35:807-8.
12. Keskin G, Kulah E, Turgay M, Kinikli G, Duman M, Tokgoz G. Pericardial tamponade and systemic sclerosis. Clin Exp Rheumatol 1996;14:701-2.
13. Hiramatsu K, Takeda N, Okumura S, Takuno H, Yasuda K. Progressive systemic sclerosis associated with massive pleural and pericardial effusion in a 90-year old woman. Jpn J Geriatr 996;33:535-9.
14. Wehbe TW, Wehbe P, Nabbout E, Oneyssi I. CREST presenting with cardiac tamponade. Med Health R I 1996;79:58-9.
15. Bulkey BH, Ridolfi RL, Salyer WR, Hutchins GM. Myocardial lesions of progressive systemic sclerosis: a cause of cardiac dysfunction. Circulation 1976;53:483-90.
16. McWhorter JE, LeRoy EC. Pericardial disease in scleroderma (systemic sclerosis). Am J Med 1974;57:566-75.
17. Smith JW, Clements PJ, Levisman J, Furst D, Ross M. Echocardiographic features of progressive systemic sclerosis (PSS): correlation with hemodynamic and post mortem studies. Am J Med 1979;66:28-33.
18. Candell-Riera J, Armadans-Gil L, Simeon CP, Castell-Conesa J, Fonollosa-Pla V, Garcia-del-Castillo H, et al. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis. Arthritis Rheum 1996;39: 1138-45.
19. Clements PJ, Lachenbruch PA, Furst DE, Paulus HE, Sterz MG. Cardiac score: a semi-quantitative measure of cardiac involvement that improves prediction of prognosis in sys-temic sclerosis. Arthritis Rheum 1991;34:1371-80.
20. Sfikakis PP, Andoniadou L, Mavrikakis M. Myocardial function and glycocorticoid administration in patients with systemic sclerosis. Arthritis Rheum 1998;41 Suppl 1:s101.